Background: Preexisting cognitive impairment and advanced age are factors that increase the risk of developing postoperative cognitive dysfunction. Because anesthetic agents interfere with cholinergic transmission and as impairment of cholinergic function is associated with cognitive decline, the authors studied how the volatile anesthetic sevoflurane affects exploratory and anxiety-like behavior in young and aged animals with a genetically modified cholinergic system.
CHOLINERGIC neurotransmission is involved in the orchestration of cognitive functions in the central nervous system, 1, 2 and alteration of cholinergic functions has been suggested to play an important role in cognitive deterioration in aging and neurodegenerative disorders such as Alzheimer disease. 3, 4 Moreover, pharmacologic modulation of nicotinic cholinergic functions in various psychiatric disorders can modify cognitive function and reduce symptoms. [5] [6] [7] Regarding postoperative cognitive dysfunction, several risk factors, such as advanced age 8 and preoperative cognitive impairment, 9 in combination with general or regional anesthesia have been associated with an increased incidence. 9, 10 Although impaired cholinergic neurotransmission has been proposed to play a key role in postoperative cognitive dysfunction, 11 the underlying mechanisms remain obscure. 12 Volatile anesthetics such as sevoflurane have a high affinity to nicotinic acetylcholine receptors (nAChRs) and may thus interfere with cholinergic nicotinic neurotransmission. [13] [14] [15] [16] [17] Furthermore, recent studies link exposure to volatile anesthetics to enhanced aggregation and toxicity of the Alzheimer disease-associated amyloid ␤ protein. 18, 19 Mice lacking the ␤ 2 subunit of the nAChR (␤ 2 KO) have a preexisting cholinergic dysfunction and display a distinct behavioral phenotype. 20 -24 Consequently, ␤ 2 KO mice have been proposed to serve as a suitable animal model for the study of cognitive deficits, particularly those influenced by nicotinic cholinergic transmission. 22, 25, 26 The aim of this investigation was to study sevofluraneinduced alterations of exploratory and anxiety-like behavior in young and aged mice with preexisting nicotinic cholinergic dysfunction.
Materials and Methods

Animals
After approval by the Karolinska Institutet Ethical Committee on Animal Research (Stockholm, Sweden; Dnr N154/05), male wild-type C57BL/6JICO (WT) mice and male mutant knockout SOPF HO ACNB2 ␤ 2 Ϫ/Ϫ (␤ 2 KO) mice were obtained from Charles Rivers Laboratories France (L'Arbresle Cedex, France). ␤ 2 KO mice were backcrossed onto a C57BL/6 background for at least 19 generations. Young animals arrived to the animal facility at 10 weeks of age and were housed individually in cages 2 weeks before the start of the experiment. Aged mice (15-18 months) were group housed in cages in the animal facility from the age of 10 weeks until the time of the experiment. Animals were housed under standard conditions with food and water ad libitum and with a circadian light cycle of 12 h light-12 h dark in the housing room. All experiments were performed during the light cycle; between 10:00 AM and 16:00 PM. Animal group characteristics are presented in table 1 . At the end of the experiment, animals were killed with carbon dioxide. Brains were dissected and immediately frozen on dry ice. This study, including care of the animals involved, was conducted according to the official edict by the French Ministry of Agriculture (Paris, France) and the recommendations of the Declaration of Helsinki. Experiments were performed according to the European Community Council guidelines 27 and in conformity to the guidelines in the Guide for the Care and Use of Laboratory Animals. 28 Therefore, the experiments were conducted in an authorized laboratory and under supervision of authorized researchers (A.W. and S.G.).
Anesthesia
Young mice were randomly assigned to control, sham, and anesthesia groups. On the day of anesthesia, control group mice remained in their cages. Mice in the sham groups were introduced into a clear plastic cylinder (Plexiglas ® ; Evonik Röhm GmbH, Darmstadt, Germany), 25 cm long and 7 cm in ID, in which they remained for 2 min, and were subsequently returned to their home cages. Mice in the anesthesia groups were introduced into the same plastic cylinder and remained there for 2 min, before administration of sevoflurane commenced. Mice were subsequently anesthetized for 2 h before being returned to their home cages. No significant behavioral differences were observed between the control and sham groups among young mice, which thus were merged into one single control group for each genotype. Hence, the old mice were randomly assigned to either control or anesthesia groups. Anesthesia was provided by administration of the volatile anesthetic sevoflurane (Sevorane ® ; Abbott France, Saint Remy sur Avre, France) via a calibrated vaporizer (Penlon Sigma Elite; Penlon Ltd., Abingdon, United Kingdom). Oxygen (100%) was fed through the vaporizer at a constant flow rate of 2 l/min, and the gas mixture was humidified before flushed into the plastic chamber. Sevoflurane concentration in the chamber was continuously measured (AION; Artema Medical AB, Stockholm, Sweden). During induction, the vaporizer was set to 8% for 30 s, and then to 5% for 3 min, and vaporizer settings were thereafter adjusted to maintain 2.6% sevoflurane in the inspired gas mixture during 2 h. The body temperature of anesthetized mice was monitored by a rectal probe (RET-3; Physitemp Instruments Inc., Clifton, NJ) connected to a thermometer (Kimo TK-2; Kimo, Montpon, France) and was maintained between 36°and 38°by the use of a heating lamp. The rectal probe was inserted after induction, as soon as the mice had lost the righting reflex. Respiratory rate was counted by observing chest movements every 15 min. After 2 h, sevoflurane administration was discontinued and mice were allowed to recover, breathing oxygen in the anesthesia chamber for 10 min. When moving spontaneously in the chamber, the mice were returned to their home cage for further recovery. Oxygen saturation was measured (Nonin 8500AV; Nonin Medical Inc., Plymouth, MN) in the hind limbs of two WT and two ␤ 2 KO mice. Oxygen saturation remained above 95% throughout the anesthetic procedure.
Behavioral Assessments
Spontaneous novelty exploration was assessed in a circular open field on two occasions, the first 24 h before anesthesia and the second 24 h after anesthesia. The open field (Manutan SA, Gonesse, France) was made of white opaque plastic material and measured 100 cm in diameter with 40-cm-high borders. Illumination was set to 110 lux in the center of the open field. Visual cues were placed on the walls of the room. Animals were originally placed in the center of the arena, and their trajectories were recorded during 30 min using an automated video tracking system (Videotrack; View-Point, Lyon, France). The speed at which the animal moved was used to break down the trajectory into navigation (speed Ͼ 11.8 cm/s), fast exploration (i.e., small movements with speed ranging from 6.8 to 11.8 cm/s) and slow exploration (i.e., very small movements at a speed below 6.8 cm/s), as previously described. 23 An index of slow versus fast movements, denominated as the exploration index, was obtained by dividing time in slow exploration with time in navigation. Refined temporospatial analysis of the trajectories was performed using Active and inactive periods were defined by the instantaneous velocity of the mouse within the open field, averaged over time windows of 0.2 s. Each time frame was thus associated with two symbols, which when combined formed a four-symbol code (PI, CI, PA, and CA) describing the state of the mouse at each time point of the experiment. Each individual experiment was then transformed into a sequence of 45,000 state symbols (30 min at 25 frames/s), which was subsequently reduced to a matrix of state transitions. This conditional matrix lists the probability of entering one state from another. The method has previously been described in detail. 24, 29 The open field apparatus was thoroughly wiped with a moist cloth between every animal, to smear out any olfactory cues left by previous mice.
Anxiety levels were assessed using an elevated plus maze, consisting of a cross-shaped platform with two arms without walls (open arms) and two arms with walls (closed arms), elevated 60 cm above the ground. The elevated plus maze provides independent measures of anxiety-like behavior (time spent on open arms) and activity (number of transitions between closed arms). 30 Light intensity in the room was set to 300 lux, and the animal was gently placed in the middle of the platform. Using a video camera mounted in the ceiling, mice's reactions to anxiogenic apparatus were stored on video tapes for off-line analysis. Time spent on the open arms and time spent at the end of the open arms was recorded, as well as the number of transitions between the walled arms. Each mouse remained in the plus maze for 10 min, and the experiment was performed only once, after the second open field test, 24 h after anesthesia.
Receptor Density
Radioligand binding of high-affinity nAChRs was performed on coronal brain sections (20 m, cut in cryostat at Ϫ20°C) incubated at room temperature with 200 pM [ 125 I]-epibatidine (PerkinElmer Inc., Waltham, MA; specific activity 2,200 Ci/mmol) in 50 mM Tris (pH 7.4) for 60 min. After incubation sections were rinsed 2 ϫ 5 min in the same buffer and briefly in distilled water. Sections were exposed on Kodak Biomax ® MS films (Eastman Kodak Company, Rochester, NY) for 24 h. Nonspecific binding was measured in the presence of 10 M nicotine and was not distinguishable from film background. For labeling of low-affinity nAChRs, [ 125 I]-␣-bungarotoxin binding was performed. Brain sections were preincubated with 50 mM Tris (pH 7.4) with 0.1% BSA for 30 min, and then incubated with 2.5 nM [ 125 I]-␣-bungarotoxin (PerkinElmer Inc.; specific activity 238 Ci/mmol) in Tris 50 mM (pH 7.4) with 0.1% BSA for 2 h. Nonspecific binding was assessed in presence of 1 mM nonlabeled nicotine. After incubation, sections were rinsed 6 ϫ 30 min in 50 mM Tris (pH 7.4) at 4°C and briefly in distilled water. Sections were then exposed on Kodak Biomax ® MS films for 8 days. For labeling of high-affinity choline uptake sites, [ 3 H]-hemicholinium binding was performed. Brain sections (20 m) were incubated with 8 nM [ 3 H]-hemicholinium (PerkinElmer Inc.; specific activity 140 Ci/mmol) at 4°C for 60 min in 50 mM Tris (pH 7.4) containing 300 mM NaCl. Nonspecific binding was performed in presence of 100 M nonlabeled hemicholinium-3. After incubation, sections were rinsed 6 ϫ 1 min each in ice-cold 50 mM Tris (pH 7.4) and briefly in distilled water. Sections were then exposed on Kodak Biomax ® MS films for 21 days. Optical density in specific brain regions was determined for each radioactive ligand by using the public domain ImageJ program † † and appropriate radioactive standards. All autoradiographic data sets were expressed in arbitrary units Ϯ interquartile range. 
Statistics
Results
Effects on Locomotor Activity and Temporospatial Organization of Trajectories
Exposure to sevoflurane for 2 h caused significant alteration in the locomotor activity 24 h after anesthesia in both young and aged mice lacking the ␤ 2 -containing nicotinic receptor subunit. In contrast, young and aged WT mice exposed to sevoflurane did not display changes in locomotor activity after 24 h, when compared with their respective control group.
In young ␤ 2 KO mice, spontaneous locomotor activity decreased both in the open field (P Ͻ 0.01; fig. 1A ) and in the plus maze (P Ͻ 0.05), whereas in the latter, it was observed as a reduction in the number of transitions between the closed arms in the apparatus ( fig. 1B ). Anesthesia provoked alterations in the characteristics of exploration in young ␤ 2 KO mice and caused alterations in three of the patterns used to define temporospatial organization of trajectories in the open field ( fig. 1C ). As illustrated in figure 1D , anesthesia increased the amount of slow velocity exploration (explo index) in young ␤ 2 KO mice compared with controls (P Ͻ 0.01). Second, the probability to venture into the center of the open field (%PA-CA) was reduced (P Ͻ 0.05), and third, the total number of large movements across the center (#PA-CA-PA) was reduced (P Ͻ 0.05) in young anesthetized ␤ 2 KO mice compared with controls.
In aged ␤ 2 KO mice, the level of locomotor activity in the open field was also reduced by anesthesia (P Ͻ 0.05; fig. 2A ). However, in the plus maze test, we were unable to detect any difference in activity levels between the different groups of aged mice (aged WT control mean ϭ 22 [95% confidence interval (CI), [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] fig. 2B ).
Nevertheless, in aged ␤ 2 KO mice, the amount of slow velocity exploration (explo index) (P Ͻ 0.05) and the probability to venture into the center (%PA-CA) (P Ͻ 0.05) were changed 24 h after anesthesia compared with controls ( fig. 2C ).
Effects on Anxiety-like Behavior
Anesthesia increased anxiety-like behavior in young ␤ 2 KO mice, as indicated by a reduction in the time venturing out on the open arms of the plus maze (P Ͻ 0.05; fig. 3A ). In contrast, we were unable to detect effects on anxiety-like behavior induced by sevoflurane anesthesia in young WT (young WT control mean ϭ 78 [95% CI, 65-91]; young WT anesthesia mean ϭ 82 [95% CI, 62-102]; fig. 3A ). We did not detect any significant differences in anxiety-like behavior in aged WT mice or in aged ␤ 2 KO mice (aged WT control mean ϭ 71 [95% CI, . 3B ).
Time spent on the open arms of the elevated plus maze did not differ significantly between young or aged WT and ␤ 2 KO control groups, indicating that neither age nor preexisting nicotinic cholinergic dysfunction per se had any effect on anxiety levels.
Effects of Age and Repeated Measurements and Genotype on Locomotor Activity
As opposed to WT, there was a significant effect of age in the ␤ 2 KO mice, as illustrated by a reduction of locomotor activity in aged ␤ 2 KO mice compared with young ␤ 2 KO mice (P Ͻ 0.001; fig. 4A ). This was confirmed in the plus maze test, where aged ␤ 2 KO mice displayed lower activity levels than did young ␤ 2 KO mice (P Ͻ 0.001; fig. 4B ). We did not detect any significant effect of age on baseline activity levels in WT mice (young WT control mean ϭ 197 [95% CI, 185-210]; aged WT control mean ϭ 188 [95% CI, 162-214]; figs. 4A and B) .
Repeating the open field test revealed an effect of habituation, i.e., locomotor distance during the second session was reduced as compared with the first session, in young WT (P Ͻ 0.01), young ␤ 2 KO (P Ͻ 0.05), aged WT (P Ͻ 0.01), and aged ␤ 2 KO (P Ͻ 0.01) mice (figs. 4C and D).
We observed a significant effect of genotype on baseline locomotor activity in young mice (P Ͻ 0.01), whereas this was not found in aged animals (aged WT 11) ; ko ؉ sevo ‫؍‬ ␤ 2 knockout anesthesia group (n ‫؍‬ 11); wt ‫؍‬ wild-type control group (n ‫؍‬ 7); wt ؉ sevo ‫؍‬ wild-type anesthesia group (n ‫؍‬ 11). * P < 0.05. -P > 0.05. 
05) but not in aged wild-type (WT) mice (not significant). (B) Activity in the plus maze, expressed as number of transitions between the walled arms, was not significantly affected by genotype or by anesthesia in aged mice. (C) Spatiotemporal organization in aged mice. Aged ␤ 2 KO mice also increased their exploration index 24 h after anesthesia compared with nonanesthetized controls (C, left) (P < 0.05). Anesthesia affected the probability for venturing into the center of the arena (%PA-CA) (P < 0.05) (C, middle). Statistical significance for planned comparisons between control and anesthesia groups is indicated above the corresponding horizontal lines. Symbols within vertical bars indicate statistical significance for planned comparison with WT control. ko ‫؍‬ ␤ 2 knockout control group (n ‫؍‬
Fig. 3. Time spent on the open arms of the elevated plus maze. Mice with higher anxiety levels spend less time on the open arms. (A) Anesthesia reduced time on open arms in young mice lacking the ␤ 2 subunit of the nicotinic acetylcholine receptor (␤ 2 KO), i.e., an increase in anxiety levels (P < 0.01). Young wild-type (WT) mice did not display any difference in anxiety levels after anesthesia. (B) In aged WT and ␤ 2 KO mice, we failed to demonstrate any significant differences in anxiety levels between groups. Statistical significance for planned comparisons between control and anesthesia groups is indicated above the corresponding horizontal lines. Symbols within vertical bars
Anesthesia
The recovery time, expressed as time to return of the righting reflex, was significantly longer (P Ͻ 0.05) in young ␤ 2 KO mice (178 Ϯ 130 s) compared with young WT mice (78 Ϯ 78 s). Among elderly mice, no significant
Fig. 4. Effects of age, repeated measurements, and genotype. (A) Comparison of locomotor activity in the open field between young and aged control mice of both genotypes.
Age was a significant factor only in knockout (KO) mice, where aged mice moved a significantly shorter distance than young mice did (P < 0.01). Among wild-type (WT) mice, no effect of age was observed. Genotype was a significant factor only in young mice, where KO mice moved a significantly longer distance than WT mice did (P < 0.01). In aged mice, no such effect of genotype was observed. Exposure to sevoflurane did not alter the density of either high-or low-affinity binding sites in any region, nor did it alter the regional cholinergic transmission indexed by the choline transporter. Amyg ‫؍‬ amygdala; CPut ‫؍‬ caudate putamen; Hippo ‫؍‬ hippocampus; ko ‫؍‬ ␤ 2 knockout control group (n ‫؍‬ 5); ko ؉ sevo ‫؍‬ ␤ 2 knockout anesthesia group (n ‫؍‬ 5); MCx ‫؍‬ motor cortex; NAc ‫؍‬ nucleus accumbens; wt ‫؍‬ wild-type control group (n ‫؍‬ 5); wt ؉ sevo ‫؍‬ wild-type anesthesia group (n ‫؍‬ 5). difference in recovery time was observed between the genotypes. During anesthesia, no differences regarding animal body temperature, sevoflurane concentration, or respiratory rate were observed between genotypes or age groups (table 1) .
(B) Effects of age on locomotor activity in the plus maze, expressed as number of transitions between the walled arms of the apparatus. Aged KO mice made fewer transitions than young KO mice did (P < 0.01), whereas no such age difference was observed in WT mice. (C) Comparison of locomotor activity in the open field between the first and second test session, i.e., effect of habituation, in young control mice of both genotypes. Locomotor activity is significantly higher in young KO mice than in young WT mice on both the first and second test occasion (P < 0.01 for both). The reduction in activity from the first to the second session is significant for all groups (P < 0.01 for all groups). (D) Comparison of locomotor activity in the open field between the first and second test session, i.e., effect of habituation, in aged control mice of both genotypes. In aged mice, there is no longer any difference between KO and WT in activity on the first and second sessions. However, within each genotype, the difference from the first to the second session is significant (P < 0.001 for both). Statistical significance for planned comparisons between groups is indi-
Two young ␤ 2 KO mice and one young WT mouse were excluded because of behavioral abnormalities before experiments. Among old mice, one ␤ 2 KO mouse was excluded because of unexpected disturbing sounds in the animal facility during experiments.
Discussion
Our study is the first to demonstrate that cognitive processes are affected by a single sevoflurane anesthesia in mutant mice lacking the ␤ 2 subunit-containing highaffinity nAChR, whereas these processes remain unaffected in WT mice.
The ␤ 2 -containing nAChR is the most widespread cholinergic receptor in the central nervous system and is implicated in modulation of cognitive function. 1 ␤ 2 KO mice have been proposed as a suitable animal model for studies related to human behavior pathology, such as attention deficit hyperactivity disorder, physiologic ageing, nicotine addiction, and Alzheimer disease. 22, 24, 26 In this context, ␤ 2 KO mice have undergone extensive behavioral testing and have been used for the study of pharmacologically induced behavioral alterations. [22] [23] [24] 26 The ␤ 2 KO mice used in our experiment carried the gene deletion since fertilization. It is therefore possible that compensatory phenomena in the expression of various nAChR subunit genes together with possible reorganization of neuronal circuits might have taken place. However, ␤ 2 subunit gene re-expression experiments have shown that the neuronal, physiologic, and behavioral phenotypes are not caused by the actual absence of ␤ 2 -containing nAChRs, but rather by their deficit in defined circuits involving, in particular, dopaminergic neurons in the ventral tegmental area. 24 We wanted to study the effects of anesthesia also in aged WT and ␤ 2 KO mice because, in humans, the risk of developing postoperative cognitive dysfunction increases with age. 8 Our assumption before the experiment was that aging would further accentuate the characteristic hyperactive phenotype of ␤ 2 KO mice. Instead, hyperactivity became attenuated with increasing age. It has previously been demonstrated that ␤ 2 KO mice display accelerated neurodegeneration upon aging, unrelated to the amount of other cholinergic receptor subtypes. 22 We therefore speculate that age-dependent neurodegenerative processes counteract the hyperactive phenotype in mutant mice, making their exploratory and anxietylike behavior more similar to that of their WT counterparts.
Because all of the observed behavioral changes after sevoflurane anesthesia have been restricted to ␤ 2 KO mice, normally functioning cholinergic neurotransmission seems to play a protective role on cognitive function after anesthesia, as illustrated by the lack of behavioral changes after sevoflurane anesthesia in WT mice. Alternatively, the lack of ␤ 2 -containing nAChRs might facilitate or permit sevoflurane-induced disturbances in neurotransmission.
One distinct characteristic phenotype in ␤ 2 KO mice is increased and disorganized locomotion in the open field. 23, 24, 29 In our study, exposure to sevoflurane attenuated the hyperactive phenotype of young ␤ 2 KO mice, which seemingly restored their normal behavior. Not only did sevoflurane anesthesia reduce their overall exploratory activity to levels similar to those of WT mice, but it also affected some patterns of sequential organization of trajectories, robustly modified in ␤ 2 KO animals as compared with WT mice. A similar, although not necessarily identical, compensatory process has previously been proposed in ␤ 2 KO mice upon chronic nicotine exposure and was interpreted as resulting from the enhancement of an opposing process mobilizing ␣ 7 nACh-R-mediated cholinergic transmission. 29 On the surface, it might seem paradoxical that an agonist of the nicotinic system and a nonselective antagonist, acting also on several other receptor systems, would induce similar behavioral changes. However, nicotinic agonists primarily act indirectly via nAChRs located on or near nerve terminals where they mediate calcium-dependent release of neurotransmitters including dopamine, norepinephrine, glutamate, ␥-aminobutyric acid, and acetylcholine. 2 Furthermore, nicotine administration has been shown to increase or decrease locomotor activity depending on dose, species, and strain. 31 A nonselective antagonist, such as sevoflurane, can act by directly suppressing the same systems, 13 and we therefore consider it possible for a nonselective antagonist to cause behavioral changes similar to those of a nicotinic agonist.
However, at this stage, and still as a working hypothesis, we suggest that the long-term effect of sevoflurane anesthesia may be due to action on the balance between nicotinic subtypes in cholinergic neurotransmission. Such intrinsic cholinergic balance is important to the proper functioning of the entire nervous system, and the absence of the ␤ 2 subunit in ␤ 2 KO mice has created a cholinergic balance different from that of WT mice. 29 In many aspects, the ␤ 2 KO mice compensate for this aberrant receptor content, but nevertheless display a distinct behavioral phenotype. 20, 21, 23 Others have proposed that the role of ␤ 2 -containing nAChRs in the modulation of cognitive processes might be compensated in the normal adult brain, and that the contribution of ␤ 2 -containing nAChRs would become apparent only in the presence of other deficits 22 or in challenging cognitive situations. 20, 21, 23 We suggest that sevoflurane anesthesia elicits changes in neurotransmission that are unveiled only in ␤ 2 KO mice already having a preexisting nicotinic cholinergic dysfunction. That is, sevoflurane might possibly act, among other mechanisms, as a modulator of ␣ 7 nicotinic receptor transmission, as has previously been suggested for isoflurane. 15 On the other hand, mice with normal nicotinic cholinergic neurotransmission seem to be able to compensate for the effects of sevoflurane anesthesia and therefore do not display detectable behavioral changes in our model.
Interestingly, simultaneously to the reduced activity observed in anesthetized ␤ 2 KO mice, an increase in anxiety-like behavior was found. Although ␤ 2 KO mice show higher levels of circulating stress hormones, they display normal anxiety levels. 22, 23 The current study shows that exposure to sevoflurane anesthesia increases anxiety-like behavior selectively in ␤ 2 KO mice but not in WT mice. One plausible hypothesis is that the observed increase in anxiety-like behavior seen in ␤ 2 KO mice after anesthesia is due to sevoflurane-induced changes in nicotinic cholinergic transmission of neuronal circuits regulating anxiety. Indeed, nicotinic cholinergic receptors modulate ␥-aminobutyric acid-mediated interneurons in the hippocampus and nucleus accumbens, 32 and in dorsal hippocampal regions, anxiety is modulated by interaction between serotonergic and cholinergic neurons. 33 Cholinergic tone in these regions mediates anxiolytic effects, 34 and both ␣ 7 and ␣ 4 ␤ 2 nAChRs are proposed to participate in the maintenance of this balance. 35 The observed increase in anxiety-like behavior seen in ␤ 2 KO mice after anesthesia may be due to sevoflurane-induced changes in ␣ 7 nAChR-mediated cholinergic transmission and/or muscarinic receptors of neuronal circuits regulating anxiety. Such hypothesis would require further pharmacologic manipulation to be tested.
Exposure to sevoflurane or desflurane for 3 h can induce long-lasting alterations in protein level expressions. 36 Such changes are proposed to contribute both to short-and long-term effects such as memory alteration and neurocognitive reactions. 37 In our study, we did not observe any changes in density of either ␤ 2 -containing nAChRs, ␣ 7 -containing nAChRs, or choline uptake sites. Whereas the direct effects of volatile anesthetics on nAChRs are well described, 38 -40 the downstream intracellular effects are more obscure. We propose that the behavioral effects noted in our study are most likely due to sevoflurane-induced changes in signaling pathways involving this receptor subtype. 41, 42 Anesthetic sensitivity of ␤ 2 KO mice has been shown to be similar to that of WT mice. 43 In our study, we maintained constant sevoflurane concentration at 2.6%, corresponding to 1 minimal alveolar concentration in mice, 44 which provided adequate anesthesia without severe respiratory depression. We also maintained normal animal body temperature during the 2-h anesthesia. Respiratory rate during anesthesia was not different between the genotypes, also indicating similar levels of anesthetic depth. We observed that after anesthesia, the time to return of the righting reflex was significantly longer in young ␤ 2 KO mice. However, young ␤ 2 KO animals weighed slightly more than WT mice did, which could account for some of the prolonged recovery time, but there is still a possibility that ␤ 2 -containing nAChRs might be involved in the recovery after anesthesia. It also suggests a role for nAChR agonists for enhanced recovery after general anesthesia. Because behavioral testing was performed 24 h after recovery and the difference in recovery time was measured in seconds, we consider it unlikely that a slower recovery from anesthesia would explain the behavioral differences noted.
We chose to evaluate locomotor activity and anxietylike behavior 24 h after anesthesia, to ascertain that the effects were not due to lingering concentrations of sevoflurane. Hence, behavioral changes observed by this time could not be attributed to an acute sevoflurane effect but were regarded as long-term effects of anesthesia. Furthermore, to address the effects of anesthesia per se, we avoided all surgical manipulation or painful stimuli to the animals during anesthesia. The observed behavioral effects are thus likely to be due solely to interaction between sevoflurane anesthesia and the particular ␤ 2 KO phenotype, because WT animals did not display behavioral changes related to sevoflurane anesthesia exposure. Behavioral effects of repeated open field testing in young and aged WT mice is a phenomenon previously described. 45 By comparing anesthetized mice with control mice, we were able to control for this effect.
In conclusion, sevoflurane anesthesia altered exploratory and anxiety-like behavior in mice lacking the ␤ 2 nAChR subunit. The duration of this effect, its cellular origin, and possible modulation by pharmacologic intervention remain to be determined. The current behavioral results suggest that brain circuits involved in organization of locomotor behavior or anxiety should be further investigated.
